Cancer-fighting virus T-VEC helps shrink tough-to-treat skin tumors

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell composition with low adverse events.

Opinion | This Isn’t COVID’s Final Act

Katz is a researcher, Perlowski is a cardiologist and long COVID patient, and Taylor is a community engagement leader. All three are involved with the

September 13, 2023

Synthetic solutions for ethical and effective drug testing

Improving human quality of life with drug treatments is a complicated issue. Drug certification, including drug safety and reliability, entails a long series of tests

July 22, 2024

Opinion | How Physicians Can Unionize and Strike With Compassion

Baum is a urologist. A few weeks ago, the longshoremen’s union shut down 14 ports along the East and Gulf Coasts. This strike of dockworkers

November 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.